MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
iPierian Inc.
Organization & Developments: iPerian
Parents
iPierian Inc.
Children
2012: Translating Nobel Science Into Novel Drugs (2012)
Company in current form put together in 2009, when iPierian, was merged with iZumi Bio, a San Francisco startup that focused on reprogramming adult cells to become “pluripotent,”
iPierian’s business strategy has long been to develop technology for using “induced pluripotent stem cells” as a tool for screening new drug candidates, it would then license the technology to Big Pharma companies.
Jumps
Finance & Acquisitions: iPerian